Overview
Aditya Maitray practices in Chennai, India. Mr. Maitray is rated as an Experienced expert by MediFind in the treatment of Hypomelanotic Disorder. His top areas of expertise are Retinal Artery Occlusion, Retinoblastoma, Retinal Detachment, Susac Syndrome, and Vitrectomy.
His clinical research consists of co-authoring 26 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hypomelanotic Disorder.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Retinal Artery OcclusionMr. Maitray isAdvanced. Learn about Retinal Artery Occlusion.
- Retinal DetachmentMr. Maitray isAdvanced. Learn about Retinal Detachment.
- RetinoblastomaMr. Maitray isAdvanced. Learn about Retinoblastoma.
- VitrectomyMr. Maitray isAdvanced. Learn about Vitrectomy.
- Experienced
- Age-Related Macular Degeneration (ARMD)Mr. Maitray isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- EndophthalmitisMr. Maitray isExperienced. Learn about Endophthalmitis.
- Gliomatosis CerebriMr. Maitray isExperienced. Learn about Gliomatosis Cerebri.
- High Potassium LevelMr. Maitray isExperienced. Learn about High Potassium Level.
- Hypomelanotic DisorderMr. Maitray isExperienced. Learn about Hypomelanotic Disorder.
- Late-Onset Retinal DegenerationMr. Maitray isExperienced. Learn about Late-Onset Retinal Degeneration.